JACKSON-MITCHELL PHARMACEUTICALS, INC. – Trademark Portfolio
Entity Type: 03
JACKSON-MITCHELL PHARMACEUTICALS, INC. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 29 (Meats & Processed Foods) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MEYENBERG. The owner is based in TURLOCK, CA.
P.O. BOX 934
TURLOCK, CA 953810934
Showing of trademarks Trademarks
Trademark Classifications
JACKSON-MITCHELL PHARMACEUTICALS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does JACKSON-MITCHELL PHARMACEUTICALS, INC. have?
JACKSON-MITCHELL PHARMACEUTICALS, INC. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does JACKSON-MITCHELL PHARMACEUTICALS, INC. file in?
JACKSON-MITCHELL PHARMACEUTICALS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 29 (Meats & Processed Foods), Class 5 (Pharmaceuticals). Class 29 covers meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits.
What are JACKSON-MITCHELL PHARMACEUTICALS, INC.'s most well-known trademarks?
JACKSON-MITCHELL PHARMACEUTICALS, INC.'s registered trademark portfolio includes well-known marks such as MEYENBERG. These are among 1 currently registered trademark in the portfolio.
What is JACKSON-MITCHELL PHARMACEUTICALS, INC.'s trademark registration success rate?
JACKSON-MITCHELL PHARMACEUTICALS, INC. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.